Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1975 Feb;30(1):80–85. doi: 10.1136/thx.30.1.80

A trial of oral delta-1-(trans)-tetrahydrocannabinol in reversible airways obstruction.

B H Davies, S Radcliffe, A Seaton, J D Graham
PMCID: PMC470248  PMID: 1124532

Abstract

Sixteen patients with proven reversible airways obstruction were admitted to a double-blind study to compare the bronchodilator effects of oral delta-1-(trans)-tetrahydrocannabinol (delta-1-THC) and salbutamol. Measurements of forced vital capacity, forced expired volume in one second, peak expiratory flow rate, and maximum expiratory flow rate at 50 percent vital capacity after 10 mg oral delta-1-THC did not differ significantly from the effect of placebo, whereas increases after salbutamol were significant. Analyses of mood, pulse rate, blood pressure, and electrocardiogram showed no important changes after oral delta-1-THC. In vitro studies with isolated tracheal muscle indicate that the activity of delta-1-THC is 1,000 times less than the equivalent dose of isoprenaline, and the effect of delta-1-THC is not abolished by beta-adrenoreceptor blocking agents. It is concluded that oral delta-1-THC, at a dose of 10 mg, does not produce clinically significant bronchodilatation in patients with reversible airways obstruction.

Full text

PDF
80

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beaconsfield P. Some cardiovascular effects of cannabis. Am Heart J. 1974 Feb;87(2):143–146. doi: 10.1016/0002-8703(74)90033-7. [DOI] [PubMed] [Google Scholar]
  2. Burstein S., Levin E., Varanelli C. Prostaglandins and cannabis. II. Inhibition of biosynthesis by the naturally occurring cannabinoids. Biochem Pharmacol. 1973 Nov 15;22(22):2905–2910. doi: 10.1016/0006-2952(73)90158-5. [DOI] [PubMed] [Google Scholar]
  3. Graham J. D., Li D. M. Cardiovascular and respiratory effects of cannabis in cat and rat. Br J Pharmacol. 1973 Sep;49(1):1–10. [PMC free article] [PubMed] [Google Scholar]
  4. Henderson R. L., Tennant F. S., Guerry R. Respiratory manifestations of hashish smoking. Arch Otolaryngol. 1972 Mar;95(3):248–251. doi: 10.1001/archotol.1972.00770080390012. [DOI] [PubMed] [Google Scholar]
  5. Horton E. W. Hypotheses on physiological roles of prostaglandins. Physiol Rev. 1969 Jan;49(1):122–161. doi: 10.1152/physrev.1969.49.1.122. [DOI] [PubMed] [Google Scholar]
  6. Jones R. T. Marihuana-induced "high": influence of expectation, setting and previous drug experience. Pharmacol Rev. 1971 Dec;23(4):359–369. [PubMed] [Google Scholar]
  7. Kubena R. K., Barry H., 3rd Stimulus characteristics of marihuana components. Nature. 1972 Feb 18;235(5338):397–398. doi: 10.1038/235397a0. [DOI] [PubMed] [Google Scholar]
  8. Legge J. S., Gaddie J., Palmer K. N. Comparison of two oral selective beta2-adrenergic stimulant drugs in bronchial asthma. Br Med J. 1971 Mar 20;1(5750):637–639. doi: 10.1136/bmj.1.5750.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. MCNAIR D. M., LORR M. AN ANALYSIS OF MOOD IN NEUROTICS. J Abnorm Psychol. 1964 Dec;69:620–627. doi: 10.1037/h0040902. [DOI] [PubMed] [Google Scholar]
  10. Tashkin D. P., Shapiro B. J., Frank I. M. Acute pulmonary physiologic effects of smoked marijuana and oral 9 -tetrahydrocannabinol in healthy young men. N Engl J Med. 1973 Aug 16;289(7):336–341. doi: 10.1056/NEJM197308162890702. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES